India easing lockdowns on cases and not vaccines risky strategy

Strategy increases chances of fresh outbreaks that would further delay economic recovery, says Oxford Economics. The rush by India’s states to end lockdowns as new coronavirus infections drop, rather than waiting for vaccination rates to rise, risks triggering fresh restrictions and holding back the nation’s recovery, according to Oxford Economics. “States are easing lockdowns based...
Read More

AstraZeneca Covid vaccine linked to rare neurological disorder in India, UK

Eleven people who received the AstraZeneca-Oxford Covid-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians in India and England have reported in two separate studies. While seven cases were reported from a medical centre in Kerala, where about 1.2 million people were administered the AstraZeneca Covid-19 vaccine, known as Covishield in India,...
Read More